PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
54.58
ESG score 50-60 - Below-average ESG territory. Benjamin Graham would scrutinize governance risks and regulatory exposure. Check Interest Coverage for financial stability.
49.62
Environmental score 40-50 - Concerning environmental levels. Seth Klarman would demand significant margin of safety given climate transition risks.
57.51
Social score 50-60 - Below-average social territory. Benjamin Graham would scrutinize reputational risks and potential litigation exposure from stakeholder issues.
56.60
Governance score 50-60 - Below-average governance territory. Benjamin Graham would scrutinize management entrenchment and potential agency costs.